Free Trial

Nevro (NVRO) Competitors

Nevro logo
$4.57 +0.07 (+1.58%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVRO vs. KIDS, TMCI, SMLR, CLPT, NNOX, TCMD, DCTH, ZIMV, CVRX, and NPCE

Should you be buying Nevro stock or one of its competitors? The main competitors of Nevro include OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), ZimVie (ZIMV), CVRx (CVRX), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry.

Nevro vs.

Nevro (NYSE:NVRO) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, community ranking, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

OrthoPediatrics has lower revenue, but higher earnings than Nevro. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nevro$425.17M0.40-$92.21M-$1.89-2.42
OrthoPediatrics$148.73M4.42-$20.97M-$1.23-22.08

Nevro presently has a consensus price target of $6.30, suggesting a potential upside of 37.83%. OrthoPediatrics has a consensus price target of $39.00, suggesting a potential upside of 43.59%. Given OrthoPediatrics' stronger consensus rating and higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than Nevro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nevro
3 Sell rating(s)
10 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.77
OrthoPediatrics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

95.5% of Nevro shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 3.2% of Nevro shares are owned by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, OrthoPediatrics had 2 more articles in the media than Nevro. MarketBeat recorded 12 mentions for OrthoPediatrics and 10 mentions for Nevro. OrthoPediatrics' average media sentiment score of 0.40 beat Nevro's score of -0.06 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nevro
0 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
OrthoPediatrics
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Nevro has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

OrthoPediatrics has a net margin of -15.00% compared to Nevro's net margin of -16.54%. OrthoPediatrics' return on equity of -5.78% beat Nevro's return on equity.

Company Net Margins Return on Equity Return on Assets
Nevro-16.54% -23.52% -10.83%
OrthoPediatrics -15.00%-5.78%-4.80%

Nevro received 192 more outperform votes than OrthoPediatrics when rated by MarketBeat users. However, 64.26% of users gave OrthoPediatrics an outperform vote while only 63.11% of users gave Nevro an outperform vote.

CompanyUnderperformOutperform
NevroOutperform Votes
503
63.11%
Underperform Votes
294
36.89%
OrthoPediatricsOutperform Votes
311
64.26%
Underperform Votes
173
35.74%

Summary

OrthoPediatrics beats Nevro on 14 of the 17 factors compared between the two stocks.

Get Nevro News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVRO vs. The Competition

MetricNevroSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$123.28M$4.55B$5.24B$19.38B
Dividend YieldN/A47.31%5.13%3.71%
P/E RatioN/A14.7559.9034.27
Price / Sales0.4058.281,218.5317.03
Price / CashN/A50.1443.8219.84
Price / Book0.567.795.325.76
Net Income-$92.21M$13.87M$122.69M$993.25M
7 Day Performance39.36%1.46%-0.17%3.26%
1 Month Performance27.33%12.36%3.49%5.71%
1 Year Performance-75.44%32.40%25.79%18.85%

Nevro Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVRO
Nevro
2.6542 of 5 stars
$4.57
+1.6%
$6.30
+37.8%
-74.8%$123.28M$425.17M0.001,215Gap Up
KIDS
OrthoPediatrics
4.0191 of 5 stars
$24.69
+1.0%
$39.00
+58.0%
-4.2%$597.89M$189.67M-20.07200Analyst Forecast
Short Interest ↑
News Coverage
TMCI
Treace Medical Concepts
0.8697 of 5 stars
$8.39
+14.9%
$8.98
+7.1%
-31.4%$522.67M$202.86M-8.47250Gap Up
SMLR
Semler Scientific
1.1039 of 5 stars
$51.86
+1.0%
N/A+46.4%$480.59M$58.94M25.30120News Coverage
Gap Up
CLPT
ClearPoint Neuro
0.5935 of 5 stars
$15.41
+5.0%
$11.33
-26.5%
+96.6%$425.09M$30.43M-22.33110Gap Up
NNOX
Nano-X Imaging
2.3376 of 5 stars
$7.27
-9.9%
$17.50
+140.7%
+46.3%$420.05M$10.68M-8.55190News Coverage
Gap Up
TCMD
Tactile Systems Technology
3.6526 of 5 stars
$17.31
+0.5%
$23.00
+32.9%
+25.8%$415.39M$285.05M26.63980Analyst Downgrade
Short Interest ↑
News Coverage
DCTH
Delcath Systems
3.8327 of 5 stars
$12.53
+9.1%
$21.50
+71.6%
+272.7%$400.58M$2.07M-9.2860Analyst Forecast
Short Interest ↓
News Coverage
Gap Up
ZIMV
ZimVie
2.7536 of 5 stars
$13.64
+1.1%
$19.50
+43.0%
-16.6%$376.45M$451.29M-1.042,700News Coverage
Positive News
CVRX
CVRx
1.7577 of 5 stars
$15.07
+6.4%
$16.67
+10.6%
-34.0%$365.66M$47.26M-5.58160Upcoming Earnings
Analyst Upgrade
Analyst Revision
News Coverage
NPCE
NeuroPace
3.5566 of 5 stars
$12.12
+1.5%
$15.00
+23.8%
-9.7%$361.76M$76.45M-12.12170News Coverage

Related Companies and Tools


This page (NYSE:NVRO) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners